A new analysis finds that relatively minor changes to Medicare's payment policies could help jump-start the fledgling market for biosimilars.

Where it stands: The market for biosimilars is weak, and that means the drugs' expected savings aren't materializing. But Medicare could help kick things up a notch, according to Avalere estimates commissioned by a coalition of biosimilars manufacturers.

By the numbers: According to Avalere's calculations, biosimilars could reach somewhere between 26% and 46% market share if Medicare picked up the tab for seniors' out-of-pocket costs for the drugs.

  • That approach could save the government as much as $5 billion and seniors as much as $3 billion over 10 years, depending on the details, the analysis says.

How it works: Doctors' financial incentives matter just as much as patients', since most biologics and biosimilars are administered at a doctor's office.

  • Medicare could save billions over the long run by simply tacking on a payment bonus for biosimilars, the analysis says.
  • Letting doctors share in the savings that biosimilars bring to Medicare wouldn't save as much money, but would do more to help biosimilars as a class gain a stronger competitive footing.

Go deeper: How to jump-start a fledgling class of new, cheaper drugs

Go deeper

Coronavirus squeezes the "sandwich generation"

Illustration: Eniola Odetunde/Axios

As the coronavirus poses risks and concerns for the youngest and oldest Americans, the generations in the middle are buckling under the increasing strain of having to take care of both.

Why it matters: People that make up the so-called sandwich generations are typically in their 30s, 40s and 50s, and in their prime working years. The increasing family and financial pressures on these workers means complications for employers, too.

Why Scranton matters again in 2020

Biden and Clinton visit Biden's childhood home in Scranton in 2016. Photo: Melina Mara/The Washington Post via Getty Images

The hometown of Joe Biden and "The Office" is polishing its perennial status as a guidepost for the nation's political mood.

Driving the news: Biden returns to Scranton, Pa., today with a campaign stop just outside the city limits at a metalworking plant, where he'll deliver remarks on a plan to create jobs and "help America build back better."

Updated 12 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Eniola Odetunde/Axios

  1. Global: Total confirmed cases as of 5 a.m. ET: 12,051,561 — Total deaths: 549,735 — Total recoveries — 6,598,230Map.
  2. U.S.: Total confirmed cases as of 5 a.m. ET: 3,055,144 — Total deaths: 132,309 — Total recoveries: 953,420 — Total tested: 37,532,612Map.
  3. 2020: Houston mayor cancels Texas Republican convention.
  4. Public health: Deaths are rising in hotspots — Déjà vu sets in as testing issues rise and PPE dwindles.
  5. Travel: United warns employees it may furlough 45% of U.S. workforce How the pandemic changed mobility habits, by state.
  6. Education: New York City schools will not fully reopen in fallHarvard and MIT sue Trump administration over rule barring foreign students from online classes.